HCAT (Health Catalyst) ROE % Adjusted to Book Value : -11.82% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Health Catalyst ROE % Adjusted to Book Value?

Health Catalyst's ROE % for the quarter that ended in Sep. 2024 was -16.55%. Health Catalyst's PB Ratio for the quarter that ended in Sep. 2024 was 1.40. Health Catalyst's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -11.82%.

Health Catalyst ROE % Adjusted to Book Value Historical Data

The historical data trend for Health Catalyst's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Catalyst ROE % Adjusted to Book Value Chart

Health Catalyst Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-7.05

-9.62

-21.03

-20.30

Health Catalyst Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-15.11	-22.01	-18.34	-14.02	-11.82

Competitive Comparison of Health Catalyst's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Health Catalyst's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Health Catalyst's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Health Catalyst's ROE % Adjusted to Book Value falls into.

Health Catalyst ROE % Adjusted to Book Value Calculation

Health Catalyst's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-29.84%	/	1.47
	=	-20.30%

Health Catalyst's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-16.55%	/	1.40
	=	-11.82%

Health Catalyst ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Health Catalyst's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Health Catalyst Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Health Catalyst Inc (NAS:HCAT) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

2YP:Germany

Address

10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095

Website

https://www.healthcatalyst.com

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Executives

Kevin Lee Freeman	officer: Chief Growth Officer	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Linda Llewelyn	officer: Chief People Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Benjamin Landry	officer: General Counsel	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Jason Alger	officer: Chief Accounting Officer	C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Daniel D. Burton	director, officer: Chief Executive Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Matthew Kolb	director	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Bryan Truman Hunt	officer: Chief Financial Officer	C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Anne Marie Bickmore	officer: COO and Chief Product Officer	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Daniel H. Orenstein	officer: General Counsel	311 ARSENAL STREET, WATERTOWN MA 02472
Duncan Gallagher	director	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Paul Horstmeier	officer: Chief Operating Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Bryan Richard Hinton	officer: Chief Technology Officer	C/O HEALTH CATALYST, 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN UT 84095
Nelli James Patrick Jr.	officer: Chief Financial Officer	C/O HEALTH CATALYST, INC., 3165 E.MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anita Pramoda	director	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Timothy G. Ferris	director	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE, #400, SALT LAKE CITY UT 84121